Find out how a contract packaging company can deliver the expertise and flexibility needed to ship pharmaceuticals internationally.
Pharmaceutical Industry White Papers
'White Papers' is specialized section provide real, actionable information to prospects. Done well, they shorten sales cycles, educate prospects and showcase a company’s thought leadership. White papers are hosted behind a registration-based landing page that captures key lead scoring information.
White Paper publication program on pharmatechglobal.net benefit from our integrated audience database. Registration can be pre-populated based on our database of professionals, providing for superior conversion rates. — If interested, Post your company's White Papers here
Rising brand drug prices are behind the increase in prescription drug spending and patient costs. In 2016, brand drugs accounted for only 11 percent of prescriptions dispensed, but more than 74 percent of total spending.
The past decade has seen a significant shift in the nature of the products being manufactured and sold by the innovative biopharmaceutical (biopharma) industry.
Moderna is focused exclusively on advancing messenger RNA (mRNA) medicines. Using mRNA – a fundamental component of human biology – as a drug, our medicines are sets of instructions that direct cells in the body to make proteins to prevent or fight disease.
Pharmaceutical companies have to contend with challenges stemming from supply chain security lapses (resulting in theft, diversion and product recalls), counterfeiting and stringent regulations. In addition to alarming safety concerns, these challenges also impair the health of the industry by adversely impacting profits, brand credibility and research initiatives.